UMB Bank n.a. Has $28,000 Stake in Chemed Co. (NYSE:CHE)

UMB Bank n.a. grew its position in Chemed Co. (NYSE:CHE) by 300.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 52 shares of the company’s stock after purchasing an additional 39 shares during the quarter. UMB Bank n.a.’s holdings in Chemed were worth $28,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Smith Salley Wealth Management grew its holdings in shares of Chemed by 1.8% during the 4th quarter. Smith Salley Wealth Management now owns 16,988 shares of the company’s stock valued at $9,000,000 after purchasing an additional 307 shares during the last quarter. Trust Co. of Vermont bought a new position in Chemed during the 4th quarter worth approximately $34,000. Hennion & Walsh Asset Management Inc. grew its holdings in Chemed by 72.5% during the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 840 shares of the company’s stock worth $445,000 after acquiring an additional 353 shares during the period. Fifth Third Wealth Advisors LLC increased its holdings in Chemed by 22.9% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 584 shares of the company’s stock worth $309,000 after purchasing an additional 109 shares in the last quarter. Finally, Bright Rock Capital Management LLC bought a new position in Chemed during the fourth quarter worth $1,060,000. 95.85% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on CHE shares. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the transaction, the chief executive officer now directly owns 101,735 shares in the company, valued at approximately $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Brian C. Judkins acquired 145 shares of the business’s stock in a transaction that occurred on Monday, December 30th. The shares were purchased at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares in the company, valued at $871,721. The trade was a 9.46 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 3.32% of the company’s stock.

Chemed Trading Up 1.7 %

Chemed stock opened at $550.99 on Monday. The firm’s 50 day simple moving average is $544.24 and its 200 day simple moving average is $563.47. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62. The firm has a market capitalization of $8.29 billion, a PE ratio of 27.84, a price-to-earnings-growth ratio of 2.15 and a beta of 0.47.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.32 EPS. Research analysts forecast that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s dividend payout ratio (DPR) is presently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.